Abstract:Background: Preterm birth is the leading cause of child death in children younger than 5 years. Large cohort studies in developed countries have shown that maternal hepatitis B virus infection is associated with preterm birth, but there is little reliable evidence from China and other developing countries, where hepatitis B virus prevalence is intermediate or high. Hence, we designed this study to investigate the association between pre-pregnancy hepatitis B virus infection and risk of preterm and early preterm birth. Methods: Between Jan 1, 2010, and Dec 31, 2012, we did a population-based cohort study using data from 489 965 rural women aged 21–49 years who had singleton livebirths from 220 counties of China who participated in the National Free Preconception Health Examination Project. Participants were divided into three groups according to their pre-pregnancy status of hepatitis B virus infection: women uninfected with hepatitis B virus (control group), women who were HBsAg positive and HBeAg negative (exposure group 1), and women who were both HBsAg and HBeAg positive (exposure group 2). The primary outcome was preterm birth (gestation at less than 37 weeks). We used log-binomial regression to estimate adjusted risk ratios (aRR) of preterm birth for women with pre-pregnancy hepatitis B virus infection, and risk of early preterm birth (gestation less than 34 weeks). Findings: 489 965 women met inclusion criteria and were included in this study; of these, 20 827 (4·3%) were infected with hepatitis B virus. Compared with women who were not infected with hepatitis B virus, women who were HBsAg positive and HBeAg negative had a 26% higher risk of preterm birth (aRR 1·26, 95% CI 1·18–1·34) and women who were both HBsAg and HBeAg positive had a 20% higher risk of preterm birth (aRR 1·20, 1·08–1·32). Compared with women who were not infected with hepatitis B virus, women who were HBsAg positive and HBeAg negative manifested an 18% higher risk of early preterm birth (gestation less than 34 weeks; aRR 1·18, 1·04–1·34) and women who were both HBsAg and HBeAg positive had a 34% higher risk of early preterm birth (aRR 1·34, 1·10–1·61). Maternal pre-pregnancy hepatitis B virus infection was independently associated with higher risk of preterm birth and early preterm birth. These associations were similar in subgroups of participants as defined by baseline characteristics. Interpretation: Besides mother-to-child transmission, the risk of preterm birth in women infected with hepatitis B virus should not be neglected. Comprehensive programmes that focus on early detection of hepatitis B virus infection before pregnancy and provide appropriate medical intervention for women infected with hepatitis B virus before and during pregnancy would be helpful in improving maternal and neonatal outcomes and reducing child mortality. Funding: Chinese Association of Maternal and Child Health Studies.

Maternal hepatitis B surface antigen carrier status and its impact on neonatal outcomes: a cohort study of 21 947 singleton newborns in China

[Impact of Maternal Hepatitis B Surface Antigen Carrier Status on Preterm Delivery in Southern China].

Effects of Maternal Hepatitis B Surface Antigen Positive Status on the Pregnancy Outcomes: A Retrospective Study in Xiamen, China, 2011-2018

Minimal adverse influence of maternal hepatitis B carrier status on perinatal outcomes and child's growth.

Association between maternal HBsAg carrier status and neonatal adverse outcomes: meta-analysis.

Maternal HBsAg carriers and adverse pregnancy outcomes: a hospital-based prospective cohort analysis.

Impact of chronic hepatitis B and HBeAg status on maternal and infant outcomes

Effects of Hbsag Positivity During Pregnancy on Adverse Maternal Outcomes: A Retrospective Database Analysis

Maternal Infection with Hepatitis B Virus Before Pregnancy and Risk of Congenital Malformations in Offspring: a Record-Linkage Study of a Large National Sample from China

Maternal Hepatitis B Virus Infection and Pregnancy Outcomes: A Hospital-based Case-control Study in Wuhan, China

Maternal hepatitis B virus carrier status and pregnancy outcomes: a prospective cohort study

Impact of Maternal Hepatitis B Carrier Status on Congenital Abnormalities: a Systematic Review and Meta-Analysis

Twin pregnancy outcomes of maternal hepatitis B virus carrier state

Chronic maternal hepatitis B virus infection and pregnancy outcome- a single center study in Kunming, China

Impact of Maternal HIV–HBV Coinfection on Pregnancy Outcomes in an Underdeveloped Rural Area of Southwest China

Hepatitis B surface antigen positive on pregnancy outcomes and BMI z-score in offspring: a population-based study, China, 2011-2018

Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome

Impact of maternal infection with hepatitis B virus on pregnancy complications and neonatal outcomes for women undergoing assisted reproductive technology treatment: A population-based study

Maternal chronic hepatitis B virus infection and the risk of preterm birth: A retrospective cohort analysis in Chinese women

Maternal Pre-Pregnancy Infection with Hepatitis B Virus and the Risk of Preterm Birth: a Population-Based Cohort Study.

Hepatitis B surface antigen carrier status and its correlation to gestational hypertension